Sunesis Pharma (SNSS) Tops Q3 EPS by 9c

November 3, 2016 9:14 AM EDT

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Sunesis Pharma (NASDAQ: SNSS) reported Q3 EPS of ($0.62), $0.09 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $600 thousand versus the consensus estimate of $600 thousand.

For earnings history and earnings-related data on Sunesis Pharma (SNSS) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment